메뉴 건너뛰기




Volumn 11, Issue 4, 2007, Pages

Clinical review: Patency of the circuit in continuous renal replacement therapy

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; ARGATROBAN; BICARBONATE; BUFFER; CALCIUM; CALCIUM ION; CITRIC ACID; DALTEPARIN; DANAPAROID; DERMATAN SULFATE; DROTRECOGIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; NAFAMSTAT; PROSTAGLANDIN; RECOMBINANT HIRUDIN; ANTICOAGULANT AGENT;

EID: 36249020143     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5937     Document Type: Review
Times cited : (232)

References (99)
  • 1
    • 34247623265 scopus 로고    scopus 로고
    • Coagulation abnormalities in critically ill patients
    • 1750988 16879728 10.1186/cc4975
    • Levi M Opal SM Coagulation abnormalities in critically ill patients Crit Care 2006, 10:222. 1750988 16879728 10.1186/cc4975
    • (2006) Crit Care , vol.10 , pp. 222
    • Levi, M.1    Opal, S.M.2
  • 2
    • 0032895812 scopus 로고    scopus 로고
    • Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration
    • 10.1046/j.1523-1755.1999.00397.x 10201024
    • Cardigan RA McGloin H Mackie IJ Machin SJ Singer M Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration Kidney Int 1999, 55:1568-1574. 10.1046/j.1523-1755.1999.00397.x 10201024
    • (1999) Kidney Int , vol.55 , pp. 1568-1574
    • Cardigan, R.A.1    McGloin, H.2    Mackie, I.J.3    Machin, S.J.4    Singer, M.5
  • 3
    • 0031032533 scopus 로고    scopus 로고
    • Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways
    • 10.1007/s001340050288 9037638
    • Salmon J Cardigan R Mackie I Cohen SL Machin S Singer M Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways Intensive Care Med 1997, 23:38-43. 10.1007/s001340050288 9037638
    • (1997) Intensive Care Med , vol.23 , pp. 38-43
    • Salmon, J.1    Cardigan, R.2    Mackie, I.3    Cohen, S.L.4    Machin, S.5    Singer, M.6
  • 5
    • 11144283199 scopus 로고    scopus 로고
    • Blood flow reductions during continuous renal replacement therapy and circuit life
    • 10.1007/s00134-004-2440-0 15448889
    • Baldwin I Bellomo R Koch B Blood flow reductions during continuous renal replacement therapy and circuit life Intensive Care Med 2004, 30:2074-2079. 10.1007/s00134-004-2440-0 15448889
    • (2004) Intensive Care Med , vol.30 , pp. 2074-2079
    • Baldwin, I.1    Bellomo, R.2    Koch, B.3
  • 6
    • 0030203864 scopus 로고    scopus 로고
    • Continuous renal replacement therapy in critically ill patients: Monitoring circuit function
    • 8862637
    • Holt AW Bierer P Bersten AD Bury LK Vedig AE Continuous renal replacement therapy in critically ill patients: Monitoring circuit function Anaesth Intensive Care 1996, 24:423-429. 8862637
    • (1996) Anaesth Intensive Care , vol.24 , pp. 423-429
    • Holt, A.W.1    Bierer, P.2    Bersten, A.D.3    Bury, L.K.4    Vedig, A.E.5
  • 7
    • 0034100133 scopus 로고    scopus 로고
    • Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: A double-blind, randomized, crossover study
    • 10.1097/00003246-200002000-00022 10708177
    • de Pont AC Oudemans-van Straaten HM Roozendaal KJ Zandstra DF Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: A double-blind, randomized, crossover study Crit Care Med 2000, 28:421-425. 10.1097/00003246-200002000-00022 10708177
    • (2000) Crit Care Med , vol.28 , pp. 421-425
    • de Pont, A.C.1    Oudemans-van Straaten, H.M.2    Roozendaal, K.J.3    Zandstra, D.F.4
  • 8
    • 0033647461 scopus 로고    scopus 로고
    • Transfusion requirements during continuous veno-venous haemofiltration: The importance of filter life
    • 10.1007/s001340000676 11193279
    • Cutts MW Thomas AN Kishen R Transfusion requirements during continuous veno-venous haemofiltration: The importance of filter life Intensive Care Med 2000, 26:1694-1697. 10.1007/s001340000676 11193279
    • (2000) Intensive Care Med , vol.26 , pp. 1694-1697
    • Cutts, M.W.1    Thomas, A.N.2    Kishen, R.3
  • 9
    • 32844461837 scopus 로고    scopus 로고
    • Anticoagulation strategies in continuous renal replacement therapy: Can the choice be evidence based?
    • 10.1007/s00134-005-0044-y 16453140
    • Oudemans-van Straaten HM Wester JP de Pont AC Schetz MR Anticoagulation strategies in continuous renal replacement therapy: Can the choice be evidence based? Intensive Care Med 2006, 32:188-202. 10.1007/ s00134-005-0044-y 16453140
    • (2006) Intensive Care Med , vol.32 , pp. 188-202
    • Oudemans-van Straaten, H.M.1    Wester, J.P.2    de Pont, A.C.3    Schetz, M.R.4
  • 10
    • 33748087100 scopus 로고    scopus 로고
    • Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH - An in vitro study
    • 10.1093/ndt/gfl068 16567341
    • Unger JK Haltern C Portz B Dohmen B Gressner A Rossaint R Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH - an in vitro study Nephrol Dial Transplant 2006, 21:2191-2201. 10.1093/ndt/gfl068 16567341
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 2191-2201
    • Unger, J.K.1    Haltern, C.2    Portz, B.3    Dohmen, B.4    Gressner, A.5    Rossaint, R.6
  • 13
    • 33747022052 scopus 로고    scopus 로고
    • How to improve dialysis adequacy in patients with vascular access problems
    • 16868897
    • Mandolfo S Borlandelli S Ravani P Imbasciati E How to improve dialysis adequacy in patients with vascular access problems J Vasc Access 2006, 7:53-59. 16868897
    • (2006) J Vasc Access , vol.7 , pp. 53-59
    • Mandolfo, S.1    Borlandelli, S.2    Ravani, P.3    Imbasciati, E.4
  • 16
    • 0035522634 scopus 로고    scopus 로고
    • Acute dialysis catheters
    • 10.1046/j.1525-139x.2001.00107.x 11851928
    • Oliver MJ Acute dialysis catheters Semin Dial 2001, 14:432-435. 10.1046/ j.1525-139x.2001.00107.x 11851928
    • (2001) Semin Dial , vol.14 , pp. 432-435
    • Oliver, M.J.1
  • 19
    • 33846657539 scopus 로고    scopus 로고
    • Sodium citrate 4% locking solution for central venous dialysis catheters - An effective, more cost-efficient alternative to heparin
    • 10.1093/ndt/gfl606 17065193
    • Grudzinski L Quinan P Kwok S Pierratos A Sodium citrate 4% locking solution for central venous dialysis catheters - an effective, more cost-efficient alternative to heparin Nephrol Dial Transplant 2007, 22:471-476. 10.1093/ndt/gfl606 17065193
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 471-476
    • Grudzinski, L.1    Quinan, P.2    Kwok, S.3    Pierratos, A.4
  • 20
    • 34248677596 scopus 로고    scopus 로고
    • Maintaining the CRRT circuit: Non-anticoagulant alternatives
    • 10.1016/S1036-7314(06)80026-3 17165492
    • Davies H Leslie G Maintaining the CRRT circuit: Non-anticoagulant alternatives Aust Crit Care 2006, 19:133-138. 10.1016/ S1036-7314(06)80026-3 17165492
    • (2006) Aust Crit Care , vol.19 , pp. 133-138
    • Davies, H.1    Leslie, G.2
  • 21
    • 0035532679 scopus 로고    scopus 로고
    • Anticoagulation in continuous renal replacement therapy
    • 11395897
    • Schetz M Anticoagulation in continuous renal replacement therapy Contrib Nephrol 2001, 132:283-303. 11395897
    • (2001) Contrib Nephrol , pp. 283-303
    • Schetz, M.1
  • 22
    • 0033984593 scopus 로고    scopus 로고
    • Factors affecting system clotting in continuous renal replacement therapy: Results of a randomized, controlled trial
    • 10661483
    • Ramesh Prasad GV Palevsky PM Burr R Lesko JM Gupta B Greenberg A Factors affecting system clotting in continuous renal replacement therapy: results of a randomized, controlled trial Clin Nephrol 2000, 53:55-60. 10661483
    • (2000) Clin Nephrol , vol.53 , pp. 55-60
    • Ramesh Prasad, G.V.1    Palevsky, P.M.2    Burr, R.3    Lesko, J.M.4    Gupta, B.5    Greenberg, A.6
  • 23
    • 33845933055 scopus 로고    scopus 로고
    • Solute removal during continuous renal replacement therapy in critically ill patients: Convection versus diffusion
    • 1550874 16646985 10.1186/cc4903
    • Ricci Z Ronco C Bachetoni A D'amico G Rossi S Alessandri E Rocco M Pietropaoli P Solute removal during continuous renal replacement therapy in critically ill patients: Convection versus diffusion Crit Care 2006, 10:R67. 1550874 16646985 10.1186/cc4903
    • (2006) Crit Care , vol.10
    • Ricci, Z.1    Ronco, C.2    Bachetoni, A.3    D'amico, G.4    Rossi, S.5    Alessandri, E.6    Rocco, M.7    Pietropaoli, P.8
  • 25
    • 0346937718 scopus 로고    scopus 로고
    • Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: Impact on filter life and azotemic control
    • 10.1159/000072492 12972719
    • Uchino S Fealy N Baldwin I Morimatsu H Bellomo R Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: Impact on filter life and azotemic control Nephron Clin Pract 2003, 94:c94-c98. 10.1159/000072492 12972719
    • (2003) Nephron Clin Pract , vol.94
    • Uchino, S.1    Fealy, N.2    Baldwin, I.3    Morimatsu, H.4    Bellomo, R.5
  • 26
    • 21044454215 scopus 로고    scopus 로고
    • Filter run time in CVVH: Pre-versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation
    • 10.1159/000083938 15711037
    • Van der Voort PH Gerritsen RT Kuiper MA Egbers PH Kingma WP Boerma EC Filter run time in CVVH: Pre-versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation Blood Purif 2005, 23:175-180. 10.1159/000083938 15711037
    • (2005) Blood Purif , vol.23 , pp. 175-180
    • Van der Voort, P.H.1    Gerritsen, R.T.2    Kuiper, M.A.3    Egbers, P.H.4    Kingma, W.P.5    Boerma, E.C.6
  • 27
    • 0035651043 scopus 로고    scopus 로고
    • Low-molecular weight proteins in end-stage renal disease: Potential toxicity and dialytic removal mechanisms
    • 11792761
    • Clark WR Gao D Low-molecular weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms J Am Soc Nephrol 2002, 13(Suppl 1):S41-S47. 11792761
    • (2002) J Am Soc Nephrol , vol.13 , Issue.SUPPL. 1
    • Clark, W.R.1    Gao, D.2
  • 28
    • 30944437636 scopus 로고    scopus 로고
    • Convective and adsorptive removal of beta2-microglobulin during predilutional and postdilutional hemofiltration
    • 10.1111/j.1523-1755.2005.00694.x 16221237
    • Padrini R Canova C Conz P Mancini E Rizzioli E Santoro A Convective and adsorptive removal of beta2-microglobulin during predilutional and postdilutional hemofiltration Kidney Int 2005, 68:2331-2337. 10.1111/ j.1523-1755.2005.00694.x 16221237
    • (2005) Kidney Int , vol.68 , pp. 2331-2337
    • Padrini, R.1    Canova, C.2    Conz, P.3    Mancini, E.4    Rizzioli, E.5    Santoro, A.6
  • 29
    • 34247525990 scopus 로고    scopus 로고
    • Improved protein-adsorption resistance of polyethersulfone membranes via surface segregation of ultrahigh molecular weight poly(styrene-alt-maleic anhydride)
    • 10.1016/j.colsurfb.2007.01.021 17379486
    • Zhu LP Zhang XX Xu L Du CH Zhu BK Xu YY Improved protein-adsorption resistance of polyethersulfone membranes via surface segregation of ultrahigh molecular weight poly(styrene-alt-maleic anhydride) Colloids Surf B Biointerfaces 2007, 57:189-197. 10.1016/j.colsurfb.2007.01.021 17379486
    • (2007) Colloids Surf B Biointerfaces , vol.57 , pp. 189-197
    • Zhu, L.P.1    Zhang, X.X.2    Xu, L.3    Du, C.H.4    Zhu, B.K.5    Xu, Y.Y.6
  • 30
    • 0037317065 scopus 로고    scopus 로고
    • New insights in dialysis membrane biocompatibility: Relevance of adsorption properties and heparin binding
    • 10.1093/ndt/18.2.252 12543877
    • Chanard J Lavaud S Randoux C Rieu P New insights in dialysis membrane biocompatibility: Relevance of adsorption properties and heparin binding Nephrol Dial Transplant 2003, 18:252-257. 10.1093/ndt/18.2.252 12543877
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 252-257
    • Chanard, J.1    Lavaud, S.2    Randoux, C.3    Rieu, P.4
  • 31
    • 0030024353 scopus 로고    scopus 로고
    • Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage
    • 8808122
    • van de Wetering J Westendorp RG van der Hoeven JG Stolk B Feuth JD Chang PC Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage J Am Soc Nephrol 1996, 7:145-150. 8808122
    • (1996) J Am Soc Nephrol , vol.7 , pp. 145-150
    • van de Wetering, J.1    Westendorp, R.G.2    van der Hoeven, J.G.3    Stolk, B.4    Feuth, J.D.5    Chang, P.C.6
  • 33
    • 33745557818 scopus 로고    scopus 로고
    • In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique
    • 16302224
    • Sperling C Houska M Brynda E Streller U Werner C In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique J Biomed Mater Res A 2006, 76:681-689. 16302224
    • (2006) J Biomed Mater Res A , vol.76 , pp. 681-689
    • Sperling, C.1    Houska, M.2    Brynda, E.3    Streller, U.4    Werner, C.5
  • 34
    • 0034865381 scopus 로고    scopus 로고
    • Renal replacement therapy: Physical properties of hollow fibers influence efficiency
    • 11482501
    • Dungen HD von HC Ronco C Kox WJ Spies CD Renal replacement therapy: physical properties of hollow fibers influence efficiency Int J Artif Organs 2001, 24:357-366. 11482501
    • (2001) Int J Artif Organs , vol.24 , pp. 357-366
    • Dungen, H.D.1    von, H.C.2    Ronco, C.3    Kox, W.J.4    Spies, C.D.5
  • 35
    • 0027358699 scopus 로고
    • Anticoagulant regimens in acute continuous hemodiafiltration: A comparative study
    • 10.1007/BF01694706 8227722
    • Bellomo R Teede H Boyce N Anticoagulant regimens in acute continuous hemodiafiltration: A comparative study Intensive Care Med 1993, 19:329-332. 10.1007/BF01694706 8227722
    • (1993) Intensive Care Med , vol.19 , pp. 329-332
    • Bellomo, R.1    Teede, H.2    Boyce, N.3
  • 36
    • 0033653649 scopus 로고    scopus 로고
    • Continuous veno-venous hemofiltration without anticoagulation in high-risk patients
    • 10.1007/s001340000691 11193272
    • Tan HK Baldwin I Bellomo R Continuous veno-venous hemofiltration without anticoagulation in high-risk patients Intensive Care Med 2000, 26:1652-1657. 10.1007/s001340000691 11193272
    • (2000) Intensive Care Med , vol.26 , pp. 1652-1657
    • Tan, H.K.1    Baldwin, I.2    Bellomo, R.3
  • 38
    • 0347320808 scopus 로고    scopus 로고
    • Continuous venovenous hemofiltration without anticoagulation
    • 10.1097/01.MAT.0000104822.30759.A7 14763495
    • Uchino S Fealy N Baldwin I Morimatsu H Bellomo R Continuous venovenous hemofiltration without anticoagulation ASAIO J 2004, 50:76-80. 10.1097/ 01.MAT.0000104822.30759.A7 14763495
    • (2004) ASAIO J , vol.50 , pp. 76-80
    • Uchino, S.1    Fealy, N.2    Baldwin, I.3    Morimatsu, H.4    Bellomo, R.5
  • 40
    • 23044466767 scopus 로고    scopus 로고
    • Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients
    • 10.1111/j.1523-1755.2005.00342.x 15882280
    • Kutsogiannis DJ Gibney RT Stollery D Gao J Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Kidney Int 2005, 67:2361-2367. 10.1111/ j.1523-1755.2005.00342.x 15882280
    • (2005) Kidney Int , vol.67 , pp. 2361-2367
    • Kutsogiannis, D.J.1    Gibney, R.T.2    Stollery, D.3    Gao, J.4
  • 41
    • 33750302263 scopus 로고    scopus 로고
    • Short filter life span during hemofiltration in sepsis: Antithrombine (AT) supplementation should be a good way to sort out this problem
    • 10.1159/000083654
    • Joannes-Boyau O Laffargue M Honore P Gauche B Fleureau C Roze H Janvier G Short filter life span during hemofiltration in sepsis: Antithrombine (AT) supplementation should be a good way to sort out this problem Blood Purif 2005, 23:149-174. 10.1159/000083654
    • (2005) Blood Purif , vol.23 , pp. 149-174
    • Joannes-Boyau, O.1    Laffargue, M.2    Honore, P.3    Gauche, B.4    Fleureau, C.5    Roze, H.6    Janvier, G.7
  • 42
    • 34247638669 scopus 로고    scopus 로고
    • Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: A case-control study
    • 1550897 16542495 10.1186/cc4853
    • du Cheyron D Bouchet B Bruel C Daubin C Ramakers M Charbonneau P Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: A case-control study Crit Care 2006, 10:R45. 1550897 16542495 10.1186/ cc4853
    • (2006) Crit Care , vol.10
    • du Cheyron, D.1    Bouchet, B.2    Bruel, C.3    Daubin, C.4    Ramakers, M.5    Charbonneau, P.6
  • 43
    • 0141819138 scopus 로고    scopus 로고
    • The protein C pathway
    • 10.1378/chest.124.3_suppl.26S 12970121
    • Esmon CT The protein C pathway Chest 2003, 124:26S-32S. 10.1378/ chest.124.3_suppl.26S 12970121
    • (2003) Chest , vol.124
    • Esmon, C.T.1
  • 44
    • 0346817408 scopus 로고    scopus 로고
    • Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis
    • 10.1007/s00134-003-1781-4 12761613
    • de Pont AC Bouman CS de Jonge E Vroom MB Büller HR Levi M Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis Intensive Care Med 2003, 29:1205. 10.1007/ s00134-003-1781-4 12761613
    • (2003) Intensive Care Med , vol.29 , pp. 1205
    • de Pont, A.C.1    Bouman, C.S.2    de Jonge, E.3    Vroom, M.B.4    Büller, H.R.5    Levi, M.6
  • 46
    • 0037302947 scopus 로고    scopus 로고
    • The use of the activated clotting time for monitoring heparin therapy in critically ill patients
    • 12594595
    • De Waele JJ Van Cauwenberghe S Hoste E Benoit D Colardyn F The use of the activated clotting time for monitoring heparin therapy in critically ill patients Intensive Care Med 2003, 29:325-328. 12594595
    • (2003) Intensive Care Med , vol.29 , pp. 325-328
    • De Waele, J.J.1    Van Cauwenberghe, S.2    Hoste, E.3    Benoit, D.4    Colardyn, F.5
  • 47
    • 4644308426 scopus 로고    scopus 로고
    • Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    • 10.1378/chest.126.3_suppl.188S 15383472
    • Hirsh J Raschke R Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004, 126:188S-203S. 10.1378/chest.126.3_suppl.188S 15383472
    • (2004) Chest , vol.126
    • Hirsh, J.1    Raschke, R.2
  • 48
    • 0029035681 scopus 로고
    • Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
    • 10.1056/NEJM199505183322003 7715641
    • Warkentin TE Levine MN Hirsh J Horsewood P Roberts RS Gent M Kelton JG Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 1995, 332:1330-1335. 10.1056/NEJM199505183322003 7715641
    • (1995) N Engl J Med , vol.332 , pp. 1330-1335
    • Warkentin, T.E.1    Levine, M.N.2    Hirsh, J.3    Horsewood, P.4    Roberts, R.S.5    Gent, M.6    Kelton, J.G.7
  • 50
    • 0033819828 scopus 로고    scopus 로고
    • Heparins and blood polymorphonuclear stimulation in haemodialysis: An expansion of the biocompatibility concept
    • 10.1093/ndt/15.10.1631 11007833
    • Leitienne P Fouque D Rigal D Adeleine P Trzeciak MC Laville M Heparins and blood polymorphonuclear stimulation in haemodialysis: An expansion of the biocompatibility concept Nephrol Dial Transplant 2000, 15:1631-1637. 10.1093/ndt/15.10.1631 11007833
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 1631-1637
    • Leitienne, P.1    Fouque, D.2    Rigal, D.3    Adeleine, P.4    Trzeciak, M.C.5    Laville, M.6
  • 51
    • 0027168729 scopus 로고
    • Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit
    • 8215953
    • Jeffrey RF Khan AA Douglas JT Will EJ Davison AM Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit Artif Organs 1993, 17:717-720. 8215953
    • (1993) Artif Organs , vol.17 , pp. 717-720
    • Jeffrey, R.F.1    Khan, A.A.2    Douglas, J.T.3    Will, E.J.4    Davison, A.M.5
  • 52
    • 0032749006 scopus 로고    scopus 로고
    • A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration
    • 10.1097/00003246-199910000-00026 10548211
    • Reeves JH Cumming AR Gallagher L O'Brien JL Santamaria JD A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration Crit Care Med 1999, 27:2224-2228. 10.1097/ 00003246-199910000-00026 10548211
    • (1999) Crit Care Med , vol.27 , pp. 2224-2228
    • Reeves, J.H.1    Cumming, A.R.2    Gallagher, L.3    O'Brien, J.L.4    Santamaria, J.D.5
  • 53
    • 34548168092 scopus 로고    scopus 로고
    • Enoxaparin versus unfractioned heparin for anticoagulation during continuous veno-venous hemofiltration - A randomized controlled cross-over study
    • Jun 12
    • Joannidis M Kountchev J Rauchenzauner M Schusterschitz N Ulmer H Mayr A Bellmann R Enoxaparin versus unfractioned heparin for anticoagulation during continuous veno-venous hemofiltration - a randomized controlled cross-over study Intensive Care Med 2007. Jun 12
    • Intensive Care Med
    • Joannidis, M.1    Kountchev, J.2    Rauchenzauner, M.3    Schusterschitz, N.4    Ulmer, H.5    Mayr, A.6    Bellmann, R.7
  • 54
    • 27744441283 scopus 로고    scopus 로고
    • In vitro and in vivo evaluation of enoxa-parin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes
    • 10.1016/j.clinthera.2005.09.008 16291417
    • Isla A Gascón AR Maynar J Arzuaga A Corral E Martín A Solinís MA Muñoz JL In vitro and in vivo evaluation of enoxa-parin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes Clin Ther 2005, 27:1444-1451. 10.1016/j.clinthera.2005.09.008 16291417
    • (2005) Clin Ther , vol.27 , pp. 1444-1451
    • Isla, A.1    Gascón, A.R.2    Maynar, J.3    Arzuaga, A.4    Corral, E.5    Martín, A.6    Solinís, M.A.7    Muñoz, J.L.8
  • 55
    • 0036145979 scopus 로고    scopus 로고
    • Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: On behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis
    • 11848446
    • Greaves M Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: On behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis Thromb Haemost 2002, 87:163-164. 11848446
    • (2002) Thromb Haemost , vol.87 , pp. 163-164
    • Greaves, M.1
  • 56
    • 4644242157 scopus 로고    scopus 로고
    • Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    • 10.1378/chest.126.3_suppl.311S 15383477
    • Warkentin TE Greinacher A Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004, 126:311S-337S. 10.1378/ chest.126.3_suppl.311S 15383477
    • (2004) Chest , vol.126
    • Warkentin, T.E.1    Greinacher, A.2
  • 58
    • 0038689143 scopus 로고    scopus 로고
    • Frequency of heparin-induced thrombocytopenia in critical care patients
    • 10.1592/phco.23.6.745.32188 12820817
    • Verma AK Levine M Shalansky SJ Carter CJ Kelton JG Frequency of heparin-induced thrombocytopenia in critical care patients Pharmacotherapy 2003, 23:745-753. 10.1592/phco.23.6.745.32188 12820817
    • (2003) Pharmacotherapy , vol.23 , pp. 745-753
    • Verma, A.K.1    Levine, M.2    Shalansky, S.J.3    Carter, C.J.4    Kelton, J.G.5
  • 61
    • 0027442550 scopus 로고
    • Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with orgaran (Org 10172)
    • 7509508
    • Magnani HN Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with orgaran (Org 10172) Thromb Haemost 1993, 70:554-561. 7509508
    • (1993) Thromb Haemost , vol.70 , pp. 554-561
    • Magnani, H.N.1
  • 62
    • 0041422394 scopus 로고    scopus 로고
    • Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD
    • 10.1345/aph.1D010 12921505
    • Dager WE White RH Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD Ann Pharmacother 2003, 37:1232-1236. 10.1345/aph.1D010 12921505
    • (2003) Ann Pharmacother , vol.37 , pp. 1232-1236
    • Dager, W.E.1    White, R.H.2
  • 63
    • 1542346478 scopus 로고    scopus 로고
    • Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction
    • 10.1592/phco.24.4.409.33168 15040656
    • Williamson DR Boulanger I Tardif M Albert M Gregoire G Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction Pharmacotherapy 2004, 24:409-414. 10.1592/ phco.24.4.409.33168 15040656
    • (2004) Pharmacotherapy , vol.24 , pp. 409-414
    • Williamson, D.R.1    Boulanger, I.2    Tardif, M.3    Albert, M.4    Gregoire, G.5
  • 64
    • 12844249370 scopus 로고    scopus 로고
    • Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia
    • 10.1345/aph.1E480 15632219
    • Tang IY Cox DS Patel K Reddy BV Nahlik L Trevino S Murray PT Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia Ann Pharmacother 2005, 39:231-236. 10.1345/aph.1E480 15632219
    • (2005) Ann Pharmacother , vol.39 , pp. 231-236
    • Tang, I.Y.1    Cox, D.S.2    Patel, K.3    Reddy, B.V.4    Nahlik, L.5    Trevino, S.6    Murray, P.T.7
  • 66
    • 0036266277 scopus 로고    scopus 로고
    • Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent
    • 10.1007/s00134-002-1249-y 12029407
    • Fiaccadori E Maggiore U Rotelli C Minari M Melfa L Cappè G Cabassi A Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent Intensive Care Med 2002, 28:586-593. 10.1007/s00134-002-1249-y 12029407
    • (2002) Intensive Care Med , vol.28 , pp. 586-593
    • Fiaccadori, E.1    Maggiore, U.2    Rotelli, C.3    Minari, M.4    Melfa, L.5    Cappè, G.6    Cabassi, A.7
  • 67
    • 0028268061 scopus 로고
    • Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure
    • 8015647
    • Davenport A Will EJ Davison AM Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure Nephron 1994, 66:431-437. 8015647
    • (1994) Nephron , vol.66 , pp. 431-437
    • Davenport, A.1    Will, E.J.2    Davison, A.M.3
  • 68
    • 0031596158 scopus 로고    scopus 로고
    • Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration
    • 10.1097/00003246-199807000-00021 9671370
    • Kozek-Langenecker SA Kettner SC Oismueller C Gonano C Speiser W Zimpfer M Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration Crit Care Med 1998, 26:1208-1212. 10.1097/00003246-199807000-00021 9671370
    • (1998) Crit Care Med , vol.26 , pp. 1208-1212
    • Kozek-Langenecker, S.A.1    Kettner, S.C.2    Oismueller, C.3    Gonano, C.4    Speiser, W.5    Zimpfer, M.6
  • 69
    • 0037083861 scopus 로고    scopus 로고
    • Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: A randomized controlled trial
    • 12060975
    • Kozek-Langenecker SA Spiss CK Gamsjager T Domenig C Zimpfer M Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: A randomized controlled trial Wien Klin Wochenschr 2002, 114:96-101. 12060975
    • (2002) Wien Klin Wochenschr , vol.114 , pp. 96-101
    • Kozek-Langenecker, S.A.1    Spiss, C.K.2    Gamsjager, T.3    Domenig, C.4    Zimpfer, M.5
  • 70
    • 0037350428 scopus 로고    scopus 로고
    • Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration
    • 10.1097/01.CCM.0000055374.77132.4D 12626998
    • Kozek-Langenecker SA Spiss CK Michalek-Sauberer A Felfernig M Zimpfer M Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration Crit Care Med 2003, 31:864-868. 10.1097/01.CCM.0000055374.77132.4D 12626998
    • (2003) Crit Care Med , vol.31 , pp. 864-868
    • Kozek-Langenecker, S.A.1    Spiss, C.K.2    Michalek-Sauberer, A.3    Felfernig, M.4    Zimpfer, M.5
  • 71
    • 33746608575 scopus 로고    scopus 로고
    • Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: Use of ionised and total/ionised calcium
    • 10.1515/CCLM.2006.164 16879061
    • Bakker AJ Boerma EC Keidel H Kingma P van der Voort PH Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: Use of ionised and total/ionised calcium Clin Chem Lab Med 2006, 44:962-966. 10.1515/CCLM.2006.164 16879061
    • (2006) Clin Chem Lab Med , vol.44 , pp. 962-966
    • Bakker, A.J.1    Boerma, E.C.2    Keidel, H.3    Kingma, P.4    van der Voort, P.H.5
  • 72
    • 0036947439 scopus 로고    scopus 로고
    • Citrate clearance in children receiving continuous venovenous renal replacement therapy
    • 10.1007/s00467-002-0963-6 12376810
    • Chadha V Garg U Warady BA Alon US Citrate clearance in children receiving continuous venovenous renal replacement therapy Pediatr Nephrol 2002, 17:819-824. 10.1007/s00467-002-0963-6 12376810
    • (2002) Pediatr Nephrol , vol.17 , pp. 819-824
    • Chadha, V.1    Garg, U.2    Warady, B.A.3    Alon, U.S.4
  • 73
    • 1242273866 scopus 로고    scopus 로고
    • Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation
    • 14989634
    • Swartz R Pasko D O'Toole J Starmann B Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation Clin Nephrol 2004, 61:134-143. 14989634
    • (2004) Clin Nephrol , vol.61 , pp. 134-143
    • Swartz, R.1    Pasko, D.2    O'Toole, J.3    Starmann, B.4
  • 74
    • 0142025049 scopus 로고    scopus 로고
    • Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients
    • 10.1097/01.CCM.0000084871.76568.E6 14530750
    • Kramer L Bauer E Joukhadar C Strobl W Gendo A Madl C Gangl A Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients Crit Care Med 2003, 31:2450-2455. 10.1097/ 01.CCM.0000084871.76568.E6 14530750
    • (2003) Crit Care Med , vol.31 , pp. 2450-2455
    • Kramer, L.1    Bauer, E.2    Joukhadar, C.3    Strobl, W.4    Gendo, A.5    Madl, C.6    Gangl, A.7
  • 75
    • 0035050839 scopus 로고    scopus 로고
    • Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation
    • 10.1097/00003246-200104000-00010 11373461
    • Meier-Kriesche HU Gitomer J Finkel K DuBose T Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation Crit Care Med 2001, 29:748-752. 10.1097/ 00003246-200104000-00010 11373461
    • (2001) Crit Care Med , vol.29 , pp. 748-752
    • Meier-Kriesche, H.U.1    Gitomer, J.2    Finkel, K.3    DuBose, T.4
  • 76
    • 0025089550 scopus 로고
    • Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients
    • 10.1038/ki.1990.300 2266683
    • Mehta RL McDonald BR Aguilar MM Ward DM Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients Kidney Int 1990, 38:976-981. 10.1038/ki.1990.300 2266683
    • (1990) Kidney Int , vol.38 , pp. 976-981
    • Mehta, R.L.1    McDonald, B.R.2    Aguilar, M.M.3    Ward, D.M.4
  • 77
    • 0000718113 scopus 로고
    • Extracorporeal management of acute renal failure patients at high risk of bleeding
    • 8320930
    • Ward DM Mehta RL Extracorporeal management of acute renal failure patients at high risk of bleeding Kidney Int Suppl 1993, 41:S237-S244. 8320930
    • (1993) Kidney Int Suppl , vol.41
    • Ward, D.M.1    Mehta, R.L.2
  • 78
    • 0034961879 scopus 로고    scopus 로고
    • Simplified citrate anticoagulation for continuous renal replacement therapy
    • 10.1046/j.1523-1755.2001.00809.x 11422774
    • Tolwani AJ Campbell RC Schenk MB Allon M Warnock DG Simplified citrate anticoagulation for continuous renal replacement therapy Kidney Int 2001, 60:370-374. 10.1046/j.1523-1755.2001.00809.x 11422774
    • (2001) Kidney Int , vol.60 , pp. 370-374
    • Tolwani, A.J.1    Campbell, R.C.2    Schenk, M.B.3    Allon, M.4    Warnock, D.G.5
  • 79
    • 0038311022 scopus 로고    scopus 로고
    • A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions
    • 10.1053/jcrc.2003.50006 12800123
    • Tobe SW Aujla P Walele AA Oliver MJ Naimark DM Perkins NJ Beardsall M A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions J Crit Care 2003, 18:121-129. 10.1053/ jcrc.2003.50006 12800123
    • (2003) J Crit Care , vol.18 , pp. 121-129
    • Tobe, S.W.1    Aujla, P.2    Walele, A.A.3    Oliver, M.J.4    Naimark, D.M.5    Perkins, N.J.6    Beardsall, M.7
  • 82
    • 1342268344 scopus 로고    scopus 로고
    • Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study
    • 10.1007/s00134-003-2047-x 14600809
    • Monchi M Berghmans D Ledoux D Canivet JL Dubois B Damas P Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study Intensive Care Med 2004, 30:260-265. 10.1007/s00134-003-2047-x 14600809
    • (2004) Intensive Care Med , vol.30 , pp. 260-265
    • Monchi, M.1    Berghmans, D.2    Ledoux, D.3    Canivet, J.L.4    Dubois, B.5    Damas, P.6
  • 83
    • 0032944876 scopus 로고    scopus 로고
    • Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding
    • 10.1046/j.1523-1755.1999.00444.x 10231464
    • Palsson R Niles JL Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding Kidney Int 1999, 55:1991-1997. 10.1046/j.1523-1755.1999.00444.x 10231464
    • (1999) Kidney Int , vol.55 , pp. 1991-1997
    • Palsson, R.1    Niles, J.L.2
  • 84
    • 0037083899 scopus 로고    scopus 로고
    • Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients
    • 12060967
    • Thoenen M Schmid ER Binswanger U Schuepbach R Aerne D Schmidlin D Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients Wien Klin Wochenschr 2002, 114:108-114. 12060967
    • (2002) Wien Klin Wochenschr , vol.114 , pp. 108-114
    • Thoenen, M.1    Schmid, E.R.2    Binswanger, U.3    Schuepbach, R.4    Aerne, D.5    Schmidlin, D.6
  • 85
    • 0036022131 scopus 로고    scopus 로고
    • A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF)
    • 10.1081/JDI-120005366 12166699
    • Hofmann RM Maloney C Ward DM Becker BN A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF) Ren Fail 2002, 24:325-335. 10.1081/JDI-120005366 12166699
    • (2002) Ren Fail , vol.24 , pp. 325-335
    • Hofmann, R.M.1    Maloney, C.2    Ward, D.M.3    Becker, B.N.4
  • 88
    • 27144486410 scopus 로고    scopus 로고
    • Continuous venovenous hemofiltration with citrate-based replacement fluid: Efficacy, safety, and impact on nutrition
    • 10.1053/j.ajkd.2005.08.010 16253732
    • Bihorac A Ross EA Continuous venovenous hemofiltration with citrate-based replacement fluid: Efficacy, safety, and impact on nutrition Am J Kidney Dis 2005, 46:908-918. 10.1053/j.ajkd.2005.08.010 16253732
    • (2005) Am J Kidney Dis , vol.46 , pp. 908-918
    • Bihorac, A.1    Ross, E.A.2
  • 89
    • 0036390012 scopus 로고    scopus 로고
    • Citrate anticoagulation in continuous venovenous hemodiafiltration: A metabolic challenge
    • 10.1007/s00134-002-1443-y 12373466
    • Gabutti L Marone C Colucci G Duchini F Schonholzer C Citrate anticoagulation in continuous venovenous hemodiafiltration: A metabolic challenge Intensive Care Med 2002, 28:1419-1425. 10.1007/ s00134-002-1443-y 12373466
    • (2002) Intensive Care Med , vol.28 , pp. 1419-1425
    • Gabutti, L.1    Marone, C.2    Colucci, G.3    Duchini, F.4    Schonholzer, C.5
  • 90
    • 0042667173 scopus 로고    scopus 로고
    • A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration
    • 10.1007/s00134-003-1801-4 12761615
    • Dorval M Madore F Courteau S Leblanc M A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration Intensive Care Med 2003, 29:1186-1189. 10.1007/s00134-003-1801-4 12761615
    • (2003) Intensive Care Med , vol.29 , pp. 1186-1189
    • Dorval, M.1    Madore, F.2    Courteau, S.3    Leblanc, M.4
  • 92
    • 0346728945 scopus 로고    scopus 로고
    • Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate
    • 10.1053/j.ajkd.2003.09.014 14712429
    • Gupta M Wadhwa NK Bukovsky R Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate Am J Kidney Dis 2004, 43:67-73. 10.1053/j.ajkd.2003.09.014 14712429
    • (2004) Am J Kidney Dis , vol.43 , pp. 67-73
    • Gupta, M.1    Wadhwa, N.K.2    Bukovsky, R.3
  • 93
    • 24044486511 scopus 로고    scopus 로고
    • Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system
    • 10.1016/j.jcrc.2005.01.001 16139156
    • Bagshaw SM Laupland KB Boiteau PJ Godinez-Luna T Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system J Crit Care 2005, 20:155-161. 10.1016/ j.jcrc.2005.01.001 16139156
    • (2005) J Crit Care , vol.20 , pp. 155-161
    • Bagshaw, S.M.1    Laupland, K.B.2    Boiteau, P.J.3    Godinez-Luna, T.4
  • 94
    • 33746531773 scopus 로고    scopus 로고
    • Safety of citrate based hemofiltration in critically ill patients at high risk for bleeding: A comparison with nadroparin
    • 16841283
    • Van der Voort PH Postma SR Kingma WP Boerma EC Van Roon EN Safety of citrate based hemofiltration in critically ill patients at high risk for bleeding: A comparison with nadroparin Int J Artif Organs 2006, 29:559-563. 16841283
    • (2006) Int J Artif Organs , vol.29 , pp. 559-563
    • Van der Voort, P.H.1    Postma, S.R.2    Kingma, W.P.3    Boerma, E.C.4    Van Roon, E.N.5
  • 95
    • 33748611903 scopus 로고    scopus 로고
    • Re: Regional citrate anticoagulation does not prolong filter survival during CVVH
    • 10.1016/j.jcrc.2006.02.002 16990102
    • Spronk PE Steenbergen H ten Kleij M Rommes JH Re: Regional citrate anticoagulation does not prolong filter survival during CVVH J Crit Care 2006, 21:291-292. 10.1016/j.jcrc.2006.02.002 16990102
    • (2006) J Crit Care , vol.21 , pp. 291-292
    • Spronk, P.E.1    Steenbergen, H.2    ten Kleij, M.3    Rommes, J.H.4
  • 96
    • 16644392433 scopus 로고    scopus 로고
    • The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation
    • 15593057
    • Gabutti L Ferrari N Mombelli G Keller F Marone C The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation J Nephrol 2004, 17:819-825. 15593057
    • (2004) J Nephrol , vol.17 , pp. 819-825
    • Gabutti, L.1    Ferrari, N.2    Mombelli, G.3    Keller, F.4    Marone, C.5
  • 97
    • 0030789993 scopus 로고    scopus 로고
    • Low polymorphonuclear cell degranulation during citrate anticoagulation: A comparison between citrate and heparin dialysis
    • 10.1093/ndt/12.7.1387 9249774
    • Bos JC Grooteman MP van Houte AJ Schoorl M van Limbeek J Nubé MJ Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysis Nephrol Dial Transplant 1997, 12:1387-1393. 10.1093/ndt/12.7.1387 9249774
    • (1997) Nephrol Dial Transplant , vol.12 , pp. 1387-1393
    • Bos, J.C.1    Grooteman, M.P.2    van Houte, A.J.3    Schoorl, M.4    van Limbeek, J.5    Nubé, M.J.6
  • 99
    • 9344259685 scopus 로고    scopus 로고
    • Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation
    • 10.1053/j.ajkd.2004.09.001 15558534
    • Wang PL Meyer MM Orloff SL Anderson S Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation Am J Kidney Dis 2004, 44:1110-1114. 10.1053/j.ajkd.2004.09.001 15558534
    • (2004) Am J Kidney Dis , vol.44 , pp. 1110-1114
    • Wang, P.L.1    Meyer, M.M.2    Orloff, S.L.3    Anderson, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.